Tomato and lycopene consumption is inversely associated with total and cause-specific mortality: a population-based cohort study, on behalf of the International Lipid Expert Panel (ILEP)

被引:20
作者
Mazidi, Mohsen [1 ]
Katsiki, Niki [2 ]
George, Elena S. [1 ]
Banach, Maciej [3 ,4 ,5 ]
机构
[1] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Geelong, Vic, Australia
[2] Aristotle Univ Thessaloniki, Hippokrat Hosp, Sch Med, Propedeut Dept Internal Med 2, Thessaloniki, Greece
[3] Med Univ Lodz, Dept Hypertens, Chair Nephrol & Hypertens, Lodz, Poland
[4] Polish Mothers Mem Hosp Res Inst PMMHRI, Lodz, Poland
[5] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland
关键词
Mortality; Tomatoes; Lycopene; CHD; Cardio-metabolic risk factors; Cerebrovascular disease; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; DIETARY PATTERNS; OXIDATIVE STRESS; PROPENSITY SCORE; NATIONAL-HEALTH; VITAMIN-C; RISK; SUPPLEMENTATION;
D O I
10.1017/S0007114519002150
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
No data exist on the associations of dietary tomato and lycopene consumption with total and cause-specific mortality. Using the National Health and Nutrition Examination Surveys 1999-2010, we evaluted the long-term impact of tomato and lycopene intake on total and cause-specific (CHD and cerebrovascular disease) mortality. We also assessed the changes in cardio-metabolic risk factors according to tomato and lycopene intake. Vital status to 31 December 2011 was ascertained. Cox proportional hazard regression models (followed by propensity score matching) were used to investigate the link between tomato and lycopene consumption total, CHD and cerebrovascular mortality. Among the 23 935 participants included (mean age = 47 center dot 6 years, 48 center dot 8 % men), 3403 deaths occurred during 76 center dot 4 months of follow-up. Tomato intake was inversely associated with total (risk ratio (RR) 0 center dot 86, 95 % CI 0 center dot 81, 0 center dot 92), CHD (RR 0 center dot 76, 95 % CI 0 center dot 70, 0 center dot 85) and cerebrovascular (RR 0 center dot 70, 95 % CI 0 center dot 62, 0 center dot 81) mortality. Similar inverse associations were found between lycopene consumption, total (RR 0 center dot 76, 95 % CI 0 center dot 72, 0 center dot 81), CHD (RR 0 center dot 73, 95 % CI 0 center dot 65, 0 center dot 83) and cerebrovascular (RR 0 center dot 71, 95 % CI 0 center dot 65, 0 center dot 78) mortality; these associations were independent of anthropometric, clinical and nutritional parameters. Age and obesity did not affect the association of tomato and lycopene consumption with total, CHD and cerebrovascular mortality. C-reactive protein significantly moderated the link between lycopene and tomato intake with total, CHD and cerebrovascular mortality. ANCOVA showed that participants with a higher tomato and lycopene consumption had a more cardio-protective profile compared with those with a lower intake. Our results highlighted the favourable effect of tomato and lycopene intake on total and cause-specific mortality as well as on cardio-metabolic risk factors. These findings should be taken into consideration for public health strategies.
引用
收藏
页码:1303 / 1310
页数:8
相关论文
共 56 条
  • [1] Dietary patterns, inflammation and the metabolic syndrome
    Ahluwalia, N.
    Andreeva, V. A.
    Kesse-Guyot, E.
    Hercberg, S.
    [J]. DIABETES & METABOLISM, 2013, 39 (02) : 99 - 110
  • [2] Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy
    Ahluwalia, Namanjeet
    Dwyer, Johanna
    Terry, Ana
    Moshfegh, Alanna
    Johnson, Clifford
    [J]. ADVANCES IN NUTRITION, 2016, 7 (01) : 121 - 134
  • [3] Best (but oft-forgotten) practices: propensity score methods in clinical nutrition research
    Ali, M. Sanni
    Groenwold, Rolf H. H.
    Klungel, Olaf H.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2016, 104 (02) : 247 - 258
  • [4] [Anonymous], 2017, J ADOLESC HLTH S, V61, pS1
  • [5] [Anonymous], 2013, MOL THER, V21, pe1
  • [6] Systematic review and meta-analysis of randomised controlled trials testing the effects of vitamin C supplementation on blood lipids
    Ashor, Ammar W.
    Siervo, Mario
    van der Velde, Femke
    Willis, Naomi D.
    Mathers, John C.
    [J]. CLINICAL NUTRITION, 2016, 35 (03) : 626 - 637
  • [7] Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies
    Aune, Dagfinn
    Keum, NaNa
    Giovannucci, Edward
    Fadnes, Lars T.
    Boffetta, Paolo
    Greenwood, Darren C.
    Tonstad, Serena
    Vatten, Lars J.
    Riboli, Elio
    Norat, Teresa
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2018, 108 (05) : 1069 - 1091
  • [8] PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016
    Banach, Maciej
    Jankowski, Piotr
    Jozwiak, Jacek
    Cybulska, Barbara
    Windak, Adam
    Guzik, Tomasz
    Mamcarf, Artur
    Broncel, Marlena
    Tomasik, Tomasz
    Rysz, Jacek
    Jankowska-Zdunczyk, Agnieszka
    Hoffman, Piotr
    Mastalerz-Migas, Agnieszka
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2017, 13 (01) : 1 - 45
  • [9] Lycopene Dietary Intervention A Pilot Study in Patients With Heart Failure
    Biddle, Martha J.
    Lennie, Terry A.
    Bricker, Gregory V.
    Kopec, Rachel E.
    Schwartz, Steven J.
    Moser, Debra K.
    [J]. JOURNAL OF CARDIOVASCULAR NURSING, 2015, 30 (03) : 205 - 212
  • [10] Böhm V, 2012, MOL NUTR FOOD RES, V56, P296, DOI [10.1002/mnfr.201100281, 10.1002/mnfr.769]